South Africa will delay introducing a new HIV and TB plan until 2024, Deputy President David Mabuza revealed on Wednesday. The plan is delayed to allow the country’s HIV and TB responses to recover from COVID-19-related disruptions. Laura Lopez Gonzalez reports for Spotlight.
New World Health Organization guidance released this week endorses the wider use of chest X-rays and artificial intelligence for tuberculosis detection. Before these technologies can be fully utilised in South Africa, some regulatory and other issues will first have to be sorted out. Catherine Tomlinson reports.
Three years ago, public sector cancer services made headlines for failing patients in multiple provinces. A few government interventions later, experts say there have been improvements, but significant issues remain. Elna Schütz reports.
New estimates of HIV in South Africa’s provinces were made public last week. This interactive table shows how South Africa’s nine provinces compare on the UNAIDS 90-90-90 targets.
While men account for only a third of South Africa’s roughly 200 000 new HIV infections in the year ending mid-2019, they account for more than half of the approximately 74 000 HIV-related deaths in the same period. This is according to new estimates released on Tuesday from the Thembisa mathematical model of HIV in South Africa.
Early results from a pivotal trial of an HIV prevention injection announced by the University of the Witwatersrand researchers have been hailed as being a “game-changer” to turn “the tide on HIV” as it effectively reduces HIV acquisition and provides women more choices in how to protect themselves. Amy Green reports.
South Africa’s childhood immunisation rates declined in 2020 compared to previous years, largely due to COVID-19 and the related lockdown. Elri Voigt asked government about the country’s catch-up plans.
In recent months, the world has seen unprecedented investment in new vaccines. Yet, while a COVID-19 vaccine proven to be safe and effective may be less than a year away, a new tuberculosis vaccine might only be ready to be rolled out in a decade, despite a massive head start over COVID-19. Amy Green takes a closer look at the race for a new vaccine for the world’s top infectious disease killer.
South Africa is consolidating its place in the race for a COVID-19 vaccine with its participation starting from next month in two new international trials of vaccine candidates. Adele Baleta reports.
